Skip to product information

European Society of Human Reproduction and Embryology Personalised Medicine In Reproduction 2025

European Society of Human Reproduction and Embryology Personalised Medicine In Reproduction 2025

Regular price $40.00 USD
Regular price $40.00 USD Sale price
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out
European Society of Human Reproduction and Embryology Personalised Medicine In Reproduction 2025

European Society of Human Reproduction and Embryology Personalised Medicine In Reproduction 2025

Regular price $40.00
Regular price $40.00 Sale price
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out
  • Share positive thoughts and feedback from your customer.

    Author
  • Share positive thoughts and feedback from your customer.

    Author
  • Share positive thoughts and feedback from your customer.

    Author
    View full details

    European Society of Human Reproduction and Embryology Personalised Medicine In Reproduction 2025

    Include: 3 videos, size: 27.93 GB
    Target Audience: reproductive endocrinologists/infertility specialists, embryologists, andrology and genetics teams, maternal–fetal medicine clinicians
     Information:

    A multidisciplinary program on precision approaches in reproductive medicine. Sessions connect molecular insights, digital tools, and patient-centered care to deliver individualized diagnostics, stimulation, embryo selection, and pregnancy management.

    What You Will Learn

    • How to build personalized diagnostic workups using genomics, hormones, imaging, and lifestyle factors

    • Tailoring ovarian stimulation and luteal support based on ovarian biology and prior response

    • Precision embryo assessment: criteria for selection, timing of transfer, and when (not) to use adjuncts

    • Individualized care pathways for endometrial receptivity, implantation failure, and recurrent pregnancy loss

    • Male-factor personalization: DNA fragmentation, genetics, and targeted treatment/selection strategies

    • Data & AI: using predictive models and dashboards to support decisions without overfitting or bias

    • Ethics & communication: consent, equity, and clear shared-decision conversations about benefits, limits, and uncertainties

    Event Details

    • Format: Case-based lectures, methodology workshops, and interactive panels

    • Structure: Diagnostics → Stimulation & Gamete Care → Embryo/Endometrium → Implantation & Pregnancy → Data/Ethics

    • Takeaways: Checklists, decision aids, and sample counseling scripts for next-day implementation

    Who Should Attend
    Reproductive endocrinologists/infertility specialists, embryologists, andrology and genetics teams, maternal–fetal medicine clinicians, nurses/midwives, counselors, data scientists/biostatisticians in ART, and trainees.

    Why Attend

    • Turn ‘one-size-fits-all’ protocols into individualized, outcomes-focused pathways

    • Integrate lab and clinic data to improve efficiency, safety, and patient experience

    • Standardize documentation and counseling for transparent, value-aligned choices

    + Topics:

    *Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the section below
    • Preconception profiling: genetic risk, metabolic/thyroid, microbiome considerations, lifestyle optimization

    • Ovarian stimulation personalization: dose algorithms, LH/HCG triggers, OHSS risk management

    • Embryo selection & transfer timing: morpho-kinetics, adjunct tests, single-embryo strategies

    • Endometrium: receptivity assessment, inflammation/infection workups, tailored luteal support

    • Implantation failure & RPL: stepwise evaluation, thrombophilia/autoimmune debates, pragmatic interventions

    • Male factor: advanced semen testing, genetics, selection techniques, varicocele/medical options

    • Data science & AI: model validation, bias control, registries, and real-world evidence

    • Ethics, equity & access: informed consent, add-on scrutiny, cost-effectiveness, patient autonomy

    • Pregnancy after ART: individualized surveillance for hypertensive disorders, GDM, multiples risk